Today at 8:24 AM ET, Gilead Sciences (NASDAQ:GILD) stock rose 12.7% to $86.25 in the pre-market session. COVID-19 patients are responding to remdesivir.
At 10:07 AM ET today, Abbott Laboratories (NYSE:ABT) stock rose by about 3.9%. The company reported its first-quarter financial results.
Johnson & Johnson stock rose 4.7% as of 12:30 PM ET today. Investors are optimistic about the company’s strong first-quarter results and a dividend hike.
Amarin (NASDAQ:AMRN) stock rose 4.7% in pre-market trading today after the company reported its preliminary first-quarter financial results.
Today at 7:55 AM ET, Gilead Sciences stock rose by 3.9% to $75.99 in the pre-market session. The company's remdesivir drug might treat COVID-19.
Johnson & Johnson (NYSE:JNJ) stock has declined by 3.2% since the beginning of 2020. However, the stock has fared better than the broader market.
Abbott Laboratories (NYSE:ABT) stock rose by about 1.0% in extended trading on Thursday. The stock rose 1.3% and closed at $86.04.
Pfizer (NYSE:PFE) stock rose 1.7% in extended trading on Thursday. The company announced that it identified a lead drug to treat COVID-19.
Johnson & Johnson (NYSE:JNJ) stock rose immediately after the company announced that an experimental coronavirus vaccine might be available by September.